Novartis AG (FRA:NOT)

Germany flag Germany · Delayed Price · Currency is EUR
139.40
+0.36 (0.26%)
At close: Feb 20, 2026
Market Cap264.18B +31.5%
Revenue (ttm)48.27B +9.6%
Net Income11.91B +17.1%
EPS6.09 +21.8%
Shares Outn/a
PE Ratio22.18
Forward PE18.34
Dividend3.50 (2.51%)
Ex-Dividend DateMar 11, 2025
Volume1,219
Average Volume996
Open138.54
Previous Close139.04
Day's Range137.24 - 139.60
52-Week Range94.56 - 142.00
Betan/a
RSI76.30
Earnings DateFeb 4, 2026

About Novartis AG

Novartis AG researches, develops, manufactures, distributes, markets, and sells pharmaceutical medicines in Switzerland and internationally. The company offers Entresto, an angiotensin receptorneprilysin inhibitor to treat symptomatic chronic heart failure with reduced ejection fraction (HFrEF); Cosentyx to treat plaque psoriasis, pso riatic arthritis, ankylosing spondylitis, and nonradiographic axial spondy loarthritis; Kisqali, a selective oral cyclin dependent inhibitor of kinases 4 and 6 (CDK4/6); Promacta/Revolade to treat immune thrombocy... [Read more]

Industry Pharmaceutical Preparations
Founded 1996
Employees 75,267
Stock Exchange Frankfurt Stock Exchange
Ticker Symbol NOT
Full Company Profile

Financial Performance

In 2025, Novartis AG's revenue was $56.67 billion, an increase of 9.57% compared to the previous year's $51.72 billion. Earnings were $13.98 billion, an increase of 17.11%.

Financial numbers in USD Financial Statements